Legis Daily

Medicare Demonstration of Coverage for Low Vision Devices Act of 2022

USA117th CongressHR-6848| House 
| Updated: 2/28/2022
Carolyn B. Maloney

Carolyn B. Maloney

Democratic Representative

New York

Cosponsors (27)
Jared Huffman (Democratic)Adam B. Schiff (Democratic)Chrissy Houlahan (Democratic)Darren Soto (Democratic)Sanford D. Bishop (Democratic)Pete Aguilar (Democratic)Bobby L. Rush (Democratic)Andy Levin (Democratic)Steve Cohen (Democratic)Scott H. Peters (Democratic)Thomas R. Suozzi (Democratic)Peter A. DeFazio (Democratic)Gus M. Bilirakis (Republican)Don Bacon (Republican)Joseph D. Morelle (Democratic)Jerrold Nadler (Democratic)Mark Takano (Democratic)Betty McCollum (Democratic)Eleanor Holmes Norton (Democratic)Joe Neguse (Democratic)Cynthia Axne (Democratic)Nydia M. Velázquez (Democratic)Brian K. Fitzpatrick (Republican)Seth Moulton (Democratic)Rashida Tlaib (Democratic)Katie Porter (Democratic)Susan Wild (Democratic)

Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Medicare Demonstration of Coverage for Low Vision Devices Act of 2022 This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration project to evaluate the fiscal impact of covering low-vision devices under Medicare in the same manner as Medicare coverage is provided for durable medical equipment. The bill defines low-vision device to mean a physician-prescribed device that magnifies, enhances, or otherwise augments or interprets visual images; the term does not include ordinary eyeglasses or contact lenses. The bill appropriates $2.5 million for FY2022 and each of the next four fiscal years for the CMS to carry out the project.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-4129
Medicare Demonstration of Coverage for Low Vision Devices Act of 2019
Feb 25, 2022
Introduced in House
Feb 25, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 28, 2022
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 116-4129
    Medicare Demonstration of Coverage for Low Vision Devices Act of 2019


  • February 25, 2022
    Introduced in House


  • February 25, 2022
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • February 28, 2022
    Referred to the Subcommittee on Health.

Health

Medicare Demonstration of Coverage for Low Vision Devices Act of 2022

USA117th CongressHR-6848| House 
| Updated: 2/28/2022
Medicare Demonstration of Coverage for Low Vision Devices Act of 2022 This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration project to evaluate the fiscal impact of covering low-vision devices under Medicare in the same manner as Medicare coverage is provided for durable medical equipment. The bill defines low-vision device to mean a physician-prescribed device that magnifies, enhances, or otherwise augments or interprets visual images; the term does not include ordinary eyeglasses or contact lenses. The bill appropriates $2.5 million for FY2022 and each of the next four fiscal years for the CMS to carry out the project.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-4129
Medicare Demonstration of Coverage for Low Vision Devices Act of 2019
Feb 25, 2022
Introduced in House
Feb 25, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 28, 2022
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 116-4129
    Medicare Demonstration of Coverage for Low Vision Devices Act of 2019


  • February 25, 2022
    Introduced in House


  • February 25, 2022
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • February 28, 2022
    Referred to the Subcommittee on Health.
Carolyn B. Maloney

Carolyn B. Maloney

Democratic Representative

New York

Cosponsors (27)
Jared Huffman (Democratic)Adam B. Schiff (Democratic)Chrissy Houlahan (Democratic)Darren Soto (Democratic)Sanford D. Bishop (Democratic)Pete Aguilar (Democratic)Bobby L. Rush (Democratic)Andy Levin (Democratic)Steve Cohen (Democratic)Scott H. Peters (Democratic)Thomas R. Suozzi (Democratic)Peter A. DeFazio (Democratic)Gus M. Bilirakis (Republican)Don Bacon (Republican)Joseph D. Morelle (Democratic)Jerrold Nadler (Democratic)Mark Takano (Democratic)Betty McCollum (Democratic)Eleanor Holmes Norton (Democratic)Joe Neguse (Democratic)Cynthia Axne (Democratic)Nydia M. Velázquez (Democratic)Brian K. Fitzpatrick (Republican)Seth Moulton (Democratic)Rashida Tlaib (Democratic)Katie Porter (Democratic)Susan Wild (Democratic)

Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted